Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
65.35 USD | -5.29% |
|
-0.79% | -13.18% |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-13.18% | 8.61B | - | ||
-3.41% | 1.36B | D | ||
-11.94% | 1.3B | B+ | ||
-0.64% | 1.23B | - | ||
-30.35% | 729M | - | - | |
-.--% | 615M | - | - | |
+7.32% | 482M | - | ||
+2.83% | 437M | - | - | |
-35.03% | 287M | - | - | |
-66.61% | 262M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- 0L3C Stock
- Ratings Henry Schein, Inc.